Non-small cell lung cancer in the new millennium: The effect of FDG-PET on stage distribution.

被引：0
|
作者：
Goodgame, B.
Morgensztern, D.
Grove, L.
Govindan, R.
机构：
[1] Barnes Jewish Hosp, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7205
引用
收藏
页码：415S / 415S
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: A decision analysis
    Scott, WJ
    Shepherd, J
    Gambhir, SS
    ANNALS OF THORACIC SURGERY, 1998, 66 (06): : 1876 - 1883
  • [32] Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
    Paul Verboom
    Harm van Tinteren
    Otto S. Hoekstra
    Egbert F. Smit
    Jan H. A. M. van den Bergh
    Ad J. M. Schreurs
    Roland A. L. M. Stallaert
    Piet C. M. van Velthoven
    Emile F. I. Comans
    Fred W. Diepenhorst
    Johan C. van Mourik
    Pieter E. Postmus
    Maarten Boers
    Els W. M. Grijseels
    Gerrit J. J. Teule
    Carin A. Uyl-de Groot
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1444 - 1449
  • [33] FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence
    Croft, DR
    Trapp, J
    Kernstine, K
    Kirchner, P
    Mullan, B
    Galvin, J
    Peterson, MW
    Gross, T
    McLennan, G
    Kern, JA
    LUNG CANCER, 2002, 36 (03) : 297 - 301
  • [34] Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
    Verboom, P
    van Tinteren, H
    Hoekstra, OS
    Smit, EF
    van den Bergh, JHAM
    Schreurs, AJM
    Stallaert, RALM
    van Velthoven, PCM
    Comans, EFI
    Diepenhorst, FW
    van Mourik, JC
    Postmus, PE
    Boers, M
    Grijseels, EWM
    Teule, GJJ
    Uyl-de Groot, CA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) : 1444 - 1449
  • [35] How effective is FDG-PET in the locoregional lymph node staging of non-small cell lung cancer?
    Türkmen, C
    Yilmazbayhan, D
    Erelel, M
    Halaç, M
    Ece, T
    Durgun, E
    Güllüoglu, M
    Selçuk, NA
    Kalayci, G
    Sönmezoglu, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S350 - S350
  • [36] Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: Analysis of false-positive FDG-PET findings
    Konishi, J
    Yamazaki, K
    Tsukamoto, E
    Tamaki, N
    Onodera, Y
    Otake, T
    Morikawa, T
    Kinoshita, I
    Dosaka-Akita, H
    Nishimura, M
    RESPIRATION, 2003, 70 (05) : 500 - 506
  • [37] FDG-PET imaging in the management of non-small-cell lung cancer
    Salminen, E
    Mac Manus, M
    ANNALS OF ONCOLOGY, 2002, 13 (03) : 357 - 360
  • [38] Small cell lung cancer: role of FDG-PET and PET/CT
    Baum, R. R.
    Prasad, V.
    ONKOLOGE, 2008, 14 (08): : 774 - +
  • [39] Subobar resection choice based on HRCT and FDG-PET/CT findings for clinical stage IA non-small cell lung cancer
    Tsutani, Y.
    Miyata, Y.
    Mimura, T.
    Ito, M.
    Kai, Y.
    Kagimoto, A.
    Nakayama, H.
    Okumura, S.
    Yoshimura, M.
    Okada, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S596 - S596
  • [40] The usefulness of fractal analysis in FDG-PET/CT images for diagnosing therapeutic effect of non-small cell lung cancer.
    Nagamachi, Shigeki
    Nonokuma, Masanari
    Mizutani, Youichi
    Terada, Tamasa
    Yoshimitsu, Kenngo
    Hirai, Toshinori
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345